L'Oreal Sales Grew in 3Q, Overcoming Sluggish China Recovery
By Ed Frankl
L'Oreal said Thursday that sales in the third quarter climbed on year, as its growing cosmetics and consumer-products businesses shrugged off slower-than-expected recovery in China.
The French beauty company posted sales of 10.00 billion euros ($10.54 billion) in the three months to Sept. 30, up from EUR9.58 billion in the same period of 2022.
On a like-for-like basis, sales growth was 11.1%, the company said.
Sales grew in all divisions, on a comparable basis, with dermatological beauty outperforming with on-year growth of 28%, while sales at consumer products, which includes brands Maybelline and Garnier, jumped 13%.
By region, comparable sales grew by double digits in Europe, North America, Latin America and its grouping of Africa, the Middle East and southern Asia, but declined in north Asia as the recovery of the beauty market in mainland China dragged.
"In a context of continued economic and geopolitical uncertainty, we remain confident in our ability to keep outperforming the market and achieve in 2023 another year of growth in sales and profits," L'Oreal's Chief Executive Nicolas Hieronimus said.
Write to Ed Frankl at edward.frankl@wsj.com
(END) Dow Jones Newswires
October 19, 2023 12:40 ET (16:40 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations